Headliners all taken from the Sept 2013 newsletter (not sure we have had a more recent update for any of the following - happy to be corrected)
Oxymorphone re-entered clinic for multi-dose PI in Sept 2013. Planning for PII if positive results achieved.
Topical Oxycodone PII (likely to be for postherpetic neuralgia) aiming for start at the end Q1 2014
Topical Oxycodone PII (likely to be for osteoarthritis) aiming for start mid year 2014
Mastitis USDA trials to continue thru 2014 with results first half of 2015
Diclofenac launch in India (Novartis and Themis) early Q1 2014
Lidocaine patch - on hold unless POH can get a partner in the "near term"
Tretinoin (for Acne)PII trial undreway - expecting results in Q1 2014
Ketaconazole (for seborrheic dermatitis) PII trial to commence mid-2014
expected news in 2014, page-6
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.923M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $1.096K | 438.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 47 | 86702619 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 59480558 | 19 |
View Market Depth
| Last trade - 15.24pm 16/08/2024 (20 minute delay) ? |
| AVE (ASX) Chart |